Breast Neoplasms, Male

Edit My Profile

"Breast Neoplasms, Male" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females.

Descriptor ID	D018567
MeSH Number(s)	C04.588.180.260 C17.800.090.500.260
Concept/Terms	Breast Neoplasms, Male Breast Neoplasms, Male Breast Neoplasm, Male Male Breast Neoplasm Neoplasm, Male Breast Tumors, Breast, Male Neoplasms, Breast, Male Neoplasms, Male Breast Breast Tumors, Male Breast Tumor, Male Male Breast Tumor Male Breast Tumors Tumor, Male Breast Tumors, Male Breast Male Breast Neoplasms Male Breast Cancer Male Breast Cancer Cancer, Male Breast Breast Carcinoma, Male Carcinoma, Male Breast Male Breast Carcinoma Breast Cancer, Male

Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms, Male".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Breast Neoplasms [C04.588.180]
Breast Neoplasms, Male [C04.588.180.260]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Breast Diseases [C17.800.090]
Breast Neoplasms [C17.800.090.500]
Breast Neoplasms, Male [C17.800.090.500.260]

Below are MeSH descriptors whose meaning is related to "Breast Neoplasms, Male".

Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms, Male".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Breast Neoplasms, Male" by people in this website by year, and whether "Breast Neoplasms, Male" was a major or minor topic of these publications.

Bar chart showing 26 publications over 16 distinct years, with a maximum of 4 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1999	0	1	1
2003	1	1	2
2004	0	1	1
2006	3	1	4
2007	1	1	2
2009	2	0	2
2010	2	1	3
2011	0	2	2
2012	0	1	1
2016	0	1	1
2017	1	0	1
2018	2	0	2
2019	1	0	1
2021	1	0	1
2022	1	0	1

Below are the most recent publications written about "Breast Neoplasms, Male" by people in Profiles.

Williams AD, Ciocca R, Sabol JL, Carp NZ. The use of neoadjuvant therapy increases the rate of breast conservation in men with locally advanced breast cancer. Clin Breast Cancer. 2022 06; 22(4):343-358.

View in: PubMed
Uttam P, Gupta RK, Hussain N. Male breast fibromatosis. Indian J Pathol Microbiol. 2021 Apr-Jun; 64(2):430-432.

View in: PubMed
Hoda RS, Arpin Iii RN, Gottumukkala RV, Hughes KS, Ly A, Brachtel EF. Diagnostic Value of Fine-Needle Aspiration in Male Breast Lesions. Acta Cytol. 2019; 63(4):319-327.

View in: PubMed
Venigalla S, Carmona R, Guttmann DM, Jain V, Freedman GM, Clark AS, Shabason JE. Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men. JAMA Oncol. 2018 10 01; 4(10):e181114.

View in: PubMed
Cui Q, Kong D, Li Z, Ahiable P, Wang K, Wu K, Wu G. Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis. Clin Breast Cancer. 2018 10; 18(5):e875-e882.

View in: PubMed
Bardia A, Mayer IA, Diamond JR, Moroose RL, Isakoff SJ, Starodub AN, Shah NC, O'Shaughnessy J, Kalinsky K, Guarino M, Abramson V, Juric D, Tolaney SM, Berlin J, Messersmith WA, Ocean AJ, Wegener WA, Maliakal P, Sharkey RM, Govindan SV, Goldenberg DM, Vahdat LT. Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2017 Jul 01; 35(19):2141-2148.

View in: PubMed
Moten AS, Jayarajan SN, Willis AI. Spindle cell carcinoma of the breast: a comprehensive analysis. Am J Surg. 2016 Apr; 211(4):716-21.

View in: PubMed
Son BH, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, Noh WC, Kim LS, Jung Y, Kim KS, Noh DY, Moon BI, Suh YJ, Lee JE, Choi DH, Kim SY, Jung SH, Yom CK, Lee H, Yang JH. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. Breast Cancer Res Treat. 2012 Jun; 133(3):1143-52.

View in: PubMed
Vranic S, Gurjeva O, Frkovic-Grazio S, Palazzo J, Tawfik O, Gatalica Z. IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast. Appl Immunohistochem Mol Morphol. 2011 Oct; 19(5):413-6.

View in: PubMed
Han SA, Park SK, Ahn SH, Lee MH, Noh DY, Kim LS, Noh WC, Jung Y, Kim KS, Kim SW. The Korean Hereditary Breast Cancer (KOHBRA) study: protocols and interim report. Clin Oncol (R Coll Radiol). 2011 Sep; 23(7):434-41.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement